Question 1

Does Viking Global Investors own TVTX stock?

Accepted Answer

No. Viking Global Investors exited its TVTX (Travere Therapeutics) position in Q2 2025. Its Q1 2025 13F listed 2,601,922 shares worth $46.6M.

Question 2

How many shares of TVTX does Viking Global Investors own?

Accepted Answer

None since Q2 2025, when Viking Global Investors exited the position. Its Q1 2025 13F listed 2,601,922 shares worth $46.6M.

Question 3

What is Viking Global Investors' TVTX position worth?

Accepted Answer

Viking Global Investors' TVTX position was worth $46.6M in its Q1 2025 13F, before the exit in Q2 2025.

Question 4

Is Viking Global Investors buying or selling TVTX?

Accepted Answer

In Q2 2025, Viking Global Investors exited its entire TVTX position.

Question 5

When did Viking Global Investors first buy TVTX?

Accepted Answer

Viking Global Investors first reported TVTX in its Q4 2024 13F and listed it in 2 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$14.80	0
2025-Q1	Decreased	2.6M	-10.3%	$46.6M	0.1%	$17.92	0
2024-Q4	New	2.9M	—	$50.6M	0.2%	$17.42	48